Evidence map›Paper›PMID 29973533›Full record

ArticleNutrients2018

Kahweol Ameliorates the Liver Inflammation through the Inhibition of NF-κB and STAT3 Activation in Primary Kupffer Cells and Primary Hepatocytes.

Hye-Young Seo, Mi-Kyung Kim, So-Hee Lee, Jae Seok Hwang, Keun-Gyu Park, Byoung Kuk Jang

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. [Kahweol improves motor function of mice with spinal cord injury by inhibiting microglial activationNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. The biological function ofFrontiers in veterinary science · 2024
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hye-Young SeoDepartment of Internal Medicine, Keimyung University School of Medicine, Daegu 42601, Korea. seo568@hanmail.net.
Mi-Kyung KimDepartment of Internal Medicine, Keimyung University School of Medicine, Daegu 42601, Korea. mdkmk@dsmc.or.kr.
So-Hee LeeDepartment of Internal Medicine, Keimyung University School of Medicine, Daegu 42601, Korea. jy16162727@naver.com.
Jae Seok HwangDepartment of Internal Medicine, Keimyung University School of Medicine, Daegu 42601, Korea. gastro@dsmc.or.kr.
Keun-Gyu ParkDepartment of Internal Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea. kpark@knu.ac.kr.
Byoung Kuk JangDepartment of Internal Medicine, Keimyung University School of Medicine, Daegu 42601, Korea. jangha106@dsmc.or.kr.
Keimyung University · KRKyungpook National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut derived bacterial endotoxins, such as lipopolysaccharide (LPS), are involved in one of the important mechanisms that lead to inflammation associated with various liver diseases, including nonalcoholic fatty liver disease and alcoholic liver disease. Kahweol is a coffee-specific diterpene present in coffee bean and exhibits anti-angiogenic and anti-inflammatory activities. However, to date, the effect of kahweol on liver inflammation remains unknown. In this study, we examined whether kahweol exhibits a protective effect by inhibiting liver inflammation in primary Kupffer cells and primary hepatocytes cultures as well as their co-cultures. Kahweol decreased the LPS-induced production of interleukin 1 alpha, interleukin 1 beta, interleukin 6, and tumor necrosis factor alpha. The inhibitory effect of kahweol on the liver inflammation was associated with the down regulation of LPS-stimulated phospho-nuclear factor kappa B and -signal transducer and activator of transcription 3 expression. These results suggest that kahweol might be a novel potent agent to treat liver inflammation induced by LPS.

Indexed as

AnimalsAnti-Inflammatory AgentsCells, CulturedCoculture TechniquesDiterpenesHepatitisHepatocytesInterleukin-1alphaInterleukin-1betaInterleukin-6Kupffer CellsLipopolysaccharidesLiver CirrhosisMice, Inbred C57BLMitogen-Activated Protein KinasesNF-kappa BAnti-Inflammatory AgentsDiterpenesIL1B protein, mouseInterleukin-1alphaInterleukin-1betaInterleukin-6interleukin-6, mousekahweollipopolysaccharide, E coli O55-B5LipopolysaccharidesMitogen-Activated Protein KinasesNF-kappa BStat3 protein, mouseSTAT3 Transcription FactorTumor Necrosis Factor-alphakahweollipopolysaccharideliver inflammationprimary hepatocyteprimary Kupffer cells

Identifiers

PMID29973533
PMCPMC6073512
OpenAlexW2810548764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.